Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Carnitine deficiency and carnitine therapy].

B Künnert1

  • 1Institut für Pathologische Anatomie, Bereiches Medizin der Karl-Marx-Universität Leipzig.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|January 1, 1988
PubMed
Summary

Carnitine facilitates fatty acid transport for energy. Carnitine deficiency, from genetic or acquired conditions, can be treated with L-carnitine, preventing severe health issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Genetic diseases of lipid storage and related disorders].

Zentralblatt fur Pathologie·1992
Same author

[Spongious glioneuronal dystrophy with diffuse fatty degeneration of the liver].

Zentralblatt fur Pathologie·1991
Same author

Description of a simple method to study some aspects of the pathogenesis of arteriosclerosis by perfusion of arterial segments.

Experimental pathology·1990
Same author

[Cholesterol metabolism in the arteriosclerotic intima].

Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie·1989
Same author

The influence of dietary low and high unsaturated fats and cholesterol on the fatty acid pattern of serum and aortic cholesteryl esters and the lipid deposits of pig aorta.

Experimental pathology·1988
Same author

[Cholesterol ester storage disease and sea-blue histiocytes].

Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie·1987

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Genetics

Context:

  • Carnitine is essential for transporting fatty acids into mitochondria for beta-oxidation.
  • Carnitine deficiency can arise from primary genetic defects or secondary to other metabolic disorders.
  • Acquired diseases can also lead to secondary carnitine deficiency.

Purpose:

  • To summarize the role of carnitine in fatty acid metabolism.
  • To highlight the causes and types of carnitine deficiency.
  • To emphasize the therapeutic potential of L-carnitine.

Summary:

  • Carnitine's primary role is facilitating fatty acid transport across the inner mitochondrial membrane for beta-oxidation.
  • Deficiencies can be inborn (genetic) or acquired, manifesting in myopathic or systemic forms.
  • L-carnitine therapy is effective for most carnitine deficiency syndromes, preventing sudden death and potentially benefiting other conditions like hyperlipoproteinemia and diabetic dyslipidemia.

Impact:

  • Effective treatment for carnitine deficiency syndromes, reducing mortality.
  • Potential therapeutic benefits for hyperlipoproteinemia and hyperlipidemic diabetes mellitus.
  • Improved understanding of metabolic pathways and genetic disease implications.

Related Experiment Videos